P/E at 61.77 vs Industry's 60.11: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Reflects Confidence Amid Sector Parity

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 61.77, slightly above the hospital industry average of 60.11. This premium, though not excessive, suggests investors are willing to pay a marginally higher multiple for the company’s earnings relative to its peers. Given the sector’s overall valuation, this premium may reflect expectations of sustained earnings growth or superior operational performance. However, the narrow gap also indicates that the stock is broadly in line with industry valuation norms rather than commanding a significant premium or discount — previously rated Hold, what is Apollo Hospitals’ current rating? The P/E ratio alone does not signal an extreme valuation stance but invites closer scrutiny of performance metrics.

Performance Across Timeframes: Strong Long-Term Gains Tempered by Recent Volatility

Examining returns over multiple periods reveals a compelling long-term growth story for Apollo Hospitals Enterprise Ltd.. Over three years, the stock has surged 61.94%, significantly outperforming the Sensex’s 21.14%. The five-year return of 159.78% and a remarkable ten-year gain of 548.81% further underscore the company’s sustained value creation. Year-to-date, the stock has appreciated 19.52%, contrasting with the Sensex’s 9.90% decline, reinforcing its resilience in a challenging market environment.

However, the short-term picture is more mixed. The stock’s one-week performance shows a decline of 0.82%, underperforming the Sensex’s 3.78% gain. Yet, over one month and three months, the stock has posted gains of 4.16% and 12.19% respectively, both outperforming the Sensex’s 2.05% and 0.93% returns. This suggests some recent volatility or profit-taking after a strong run, but the medium-term momentum remains positive — is this a temporary correction or a shift in trend?

Moving Average Configuration: Above Medium and Long-Term MAs, Below 5-Day MA

The technical setup for Apollo Hospitals Enterprise Ltd. shows the stock trading above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling a generally bullish medium to long-term trend. However, it currently sits just below its 5-day moving average, indicating a short-term pullback or consolidation phase. This configuration often points to a recent pause in momentum after a rally, with the potential for either a continuation or a deeper correction depending on upcoming market catalysts. The proximity to its 52-week high, just 2.79% away, further highlights the stock’s relative strength over the past year.

Relative Performance: Consistent Outperformance of Sensex Across Most Periods

Across nearly all measured timeframes, Apollo Hospitals Enterprise Ltd. has outperformed the Sensex. The one-year return of 20.13% contrasts sharply with the Sensex’s 5.89% decline, while the three-month return of 12.19% also exceeds the Sensex’s 0.93%. Even the year-to-date gain of 19.52% stands out against the Sensex’s negative 9.90%. This consistent alpha generation highlights the stock’s relative strength within the broader market context. The only exception is the one-week period, where the stock’s 0.82% loss contrasts with the Sensex’s 3.78% gain, suggesting a brief divergence in momentum.

Sector Context: Hospital Industry Shows Mixed Results Amid Varied Stock Performances

The hospital sector, to which Apollo Hospitals Enterprise Ltd. belongs, has exhibited a mixed performance profile recently. While some stocks in the sector have posted gains, others have remained flat or declined, reflecting a heterogeneous environment. The sector’s average P/E of 60.11 indicates a valuation level that is broadly in line with Apollo Hospitals itself, suggesting that the company’s premium is not an outlier but rather consistent with sector norms. This context is important for investors analysing whether the stock’s valuation premium is justified by sector fundamentals or company-specific factors.

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Hold. The rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technical indicators. While the current rating is not disclosed, the data-driven approach behind the reassessment considers the stock’s premium valuation, strong long-term performance, and recent technical signals. This raises the question — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: Data Reflects a Stock Balancing Premium Valuation with Strong Long-Term Performance

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight premium to its sector, supported by robust long-term returns and a generally bullish technical setup. The short-term momentum shows some hesitation, with a recent dip below the 5-day moving average and a one-week underperformance versus the Sensex. However, the stock remains close to its 52-week high and well above key medium and long-term moving averages, signalling underlying strength. The sector’s mixed performance and the company’s previous Hold rating, now reassessed, add layers of complexity to the investment case — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →